These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11506775)

  • 21. Community-acquired bacteria frequently detected by means of quantitative polymerase chain reaction in nosocomial early-onset ventilator-associated pneumonia.
    Apfalter P; Stoiser B; Barousch W; Nehr M; Kramer L; Burgmann H
    Crit Care Med; 2005 Jul; 33(7):1492-8. PubMed ID: 16003053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Obtain best usage of meropenem dose in severe infections. Results of an observational multicenter study].
    Alvarez-Sánchez B; Alvarez-Lerma F; Romero J; Fernández L; Ruiz F; Sancho H
    Rev Esp Quimioter; 2008 Sep; 21(3):143-8. PubMed ID: 18792813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ventilator-associated pulmonary infection: the germ theory of disease remains viable.
    Solomkin JS
    Microbes Infect; 2005 Feb; 7(2):279-91. PubMed ID: 15777668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy for ventilator-associated pneumonia: what works, what doesn't.
    Hijazi M; Al-Ansari M
    Respir Care Clin N Am; 2004 Sep; 10(3):341-58, vi. PubMed ID: 15458732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nosocomial infections and resistance pattern of common bacterial isolates in an intensive care unit of a tertiary hospital in Nigeria: A 4-year review.
    Iliyasu G; Daiyab FM; Tiamiyu AB; Abubakar S; Habib ZG; Sarki AM; Habib AG
    J Crit Care; 2016 Aug; 34():116-20. PubMed ID: 27288622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit.
    Chastre J; Luyt CE; Combes A; Trouillet JL
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S75-81. PubMed ID: 16894519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nosocomial pneumonia. Diagnostic and therapeutic considerations.
    Cunha BA
    Med Clin North Am; 2001 Jan; 85(1):79-114. PubMed ID: 11190353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection.
    Jaruratanasirikul S; Sriwiriyajan S; Punyo J
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1337-9. PubMed ID: 15793108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of 3-hour and 30-minute infusion regimens for meropenem in patients with hospital acquired pneumonia in intensive care unit: a randomized controlled clinical trial].
    Wang Z; Shan T; Liu Y; Ding S; Li C; Zhai Q; Chen X; Du B; Li Y; Zhang J; Wang H; Wu D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Sep; 26(9):644-9. PubMed ID: 25230866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial.
    Torres A; Zhong N; Pachl J; Timsit JF; Kollef M; Chen Z; Song J; Taylor D; Laud PJ; Stone GG; Chow JW
    Lancet Infect Dis; 2018 Mar; 18(3):285-295. PubMed ID: 29254862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study.
    West M; Boulanger BR; Fogarty C; Tennenberg A; Wiesinger B; Oross M; Wu SC; Fowler C; Morgan N; Kahn JB
    Clin Ther; 2003 Feb; 25(2):485-506. PubMed ID: 12749509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study.
    Marik PE; Careau P
    Chest; 1999 Jan; 115(1):178-83. PubMed ID: 9925081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agreement between quantitative cultures of postintubation tracheal aspiration and plugged telescoping catheter, protected specimen brush, or BAL for the diagnosis of nosocomial pneumonia.
    Clec'h C; Jauréguy F; Hamza L; Karoubi P; Fosse JP; Hamdi A; Vincent F; Gonzalez F; Cohen Y
    Chest; 2006 Oct; 130(4):956-61. PubMed ID: 17035424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nosocomial pneumonia in the intensive care unit of a Brazilian university hospital: an analysis of the time span from admission to disease onset.
    Gusmão ME; Dourado I; Fiaccone RL
    Am J Infect Control; 2004 Jun; 32(4):209-14. PubMed ID: 15175615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial.
    Alvarez-Lerma F; Insausti-Ordeñana J; Jordá-Marcos R; Maraví-Poma E; Torres-Martí A; Nava J; Martínez-Pellús A; Palomar M; Barcenilla F;
    Intensive Care Med; 2001 Mar; 27(3):493-502. PubMed ID: 11355117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia.
    Hayon J; Figliolini C; Combes A; Trouillet JL; Kassis N; Dombret MC; Gibert C; Chastre J
    Am J Respir Crit Care Med; 2002 Jan; 165(1):41-6. PubMed ID: 11779728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
    Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of Ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015.
    Wałaszek M; Różańska A; Wałaszek MZ; Wójkowska-Mach J;
    BMC Infect Dis; 2018 Jul; 18(1):308. PubMed ID: 29976151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.